个人中心 - 老虎社区

Shell海贝

IP属地：山东

帖子 · 3帖子 · 3
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- Shell海贝Shell海贝
  ·07-26
  短期回调，现在只是山脚
  667 评论
  点赞
  分享
  举报
- Shell海贝Shell海贝
  ·2023-06-25
  226 评论
  点赞
  分享
  举报
- Shell海贝Shell海贝
  ·2022-08-03
  6！，其他th
  Cardiff Oncology Inc盘中异动早盘急速下挫5.20%
  北京时间2022年08月01日23时18分，Cardiff Oncology Inc股票出现波动，股价快速下跌5.20%。Cardiff Oncology Inc股票所在的生物技术行业中，整体跌幅为0.27%。Cardiff Oncology Inc公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，致力于为癌症患者开发具有最大医疗需求的适应症，包括KRAS突变的转移性结直肠癌、胰腺癌、转移性去势抵抗前列腺癌和白血病。
  Cardiff Oncology Inc盘中异动早盘急速下挫5.20%
  1,072 评论
  点赞
  分享
  举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3476700896354942","uuid":"3476700896354942","gmtCreate":1514338252965,"gmtModify":1514338252965,"name":"Shell海贝","pinyin":"shellhbshellhaibei","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":19,"tweetSize":3,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":4,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.67%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"山东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":331771602346088,"gmtCreate":1722005837374,"gmtModify":1722006188305,"author":{"id":"3476700896354942","authorId":"3476700896354942","name":"Shell海贝","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3476700896354942","authorIdStr":"3476700896354942"},"themes":[],"htmlText":"短期回调，现在只是山脚","listText":"短期回调，现在只是山脚","text":"短期回调，现在只是山脚","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/331771602346088","isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":191235509969056,"gmtCreate":1687706675463,"gmtModify":1687743572414,"author":{"id":"3476700896354942","authorId":"3476700896354942","name":"Shell海贝","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3476700896354942","authorIdStr":"3476700896354942"},"themes":[],"htmlText":"","listText":"","text":"","images":[{"img":"https://static.tigerbbs.com/804e69adc628b7fb49aa522ca1b1d58c","width":"1125","height":"1476"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/191235509969056","isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":685179190,"gmtCreate":1659522363513,"gmtModify":1659522687422,"author":{"id":"3476700896354942","authorId":"3476700896354942","name":"Shell海贝","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3476700896354942","authorIdStr":"3476700896354942"},"themes":[],"htmlText":"6！，其他th&nbsp;","listText":"6！，其他th&nbsp;","text":"6！，其他th","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/685179190","repostId":"2256664143","repostType":2,"repost":{"id":"2256664143","pubTimestamp":1659370271,"share":"https://www.laohu8.com/m/news/2256664143?lang=&edition=full","pubTime":"2022-08-02 00:11","market":"us","language":"zh","title":"Cardiff Oncology Inc盘中异动 早盘急速下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2256664143","media":"自选股智能写手","summary":"北京时间2022年08月01日23时18分，Cardiff Oncology Inc股票出现波动，股价快速下跌5.20%。Cardiff Oncology Inc股票所在的生物技术行业中，整体跌幅为0.27%。Cardiff Oncology Inc公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，致力于为癌症患者开发具有最大医疗需求的适应症，包括KRAS突变的转移性结直肠癌、胰腺癌、转移性去势抵抗前列腺癌和白血病。","content":"<html><body><article><p>北京时间2022年08月01日23时18分，Cardiff Oncology Inc（CRDF.us）股票出现波动，股价快速下跌5.20%。截至发稿，该股报2.10美元/股，成交量12.3874万股，<span>换手率</span>0.29%，振幅6.79%。</p><p>最近的财报数据显示，该股实现<span>营业收入</span>74000.00美元，<span>净利润</span>-10.99百万美元，<span>每股收益</span>-0.25美元，<span>毛利</span>43000.00美元，市盈率-2.50倍。</p><p>机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。</p><p>Cardiff Oncology Inc股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，<a href=\"https://laohu8.com/S/ADILW\">Adial Pharmaceuticals Inc</a> C/ Wts 31/07/2023 (To Pur Com)、<a href=\"https://laohu8.com/S/VRAX\">Virax Biolabs Group Limited</a>、<a href=\"https://laohu8.com/S/CTXRW\">Citius Pharmaceuticals Inc</a> C/Wts 00/00/2022 (To Pur Com)涨幅较大，Geovax Labs Inc、Virax Biolabs Group Limited、Tonix Pharmaceuticals Hldg Corp较为活跃，换手率分别为567.73%、230.74%、46.75%，振幅较大的相关个股有<a href=\"https://laohu8.com/S/ADIL\">Adial Pharmaceuticals</a> Inc C/ Wts 31/07/2023 (To Pur Com)、Virax Biolabs Group Limited、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)，振幅分别为380.19%、120.74%、98.31%。</p><p>Cardiff Oncology Inc公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，致力于为癌症患者开发具有最大医疗需求的适应症，包括KRAS突变的转移性结直肠癌、胰腺癌、转移性去势抵抗前列腺癌和白血病。</p><p>（以上内容为自选股<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cardiff Oncology Inc盘中异动 早盘急速下挫5.20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCardiff Oncology Inc盘中异动 早盘急速下挫5.20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-02 00:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080200120583d473aa&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2022年08月01日23时18分，Cardiff Oncology Inc（CRDF.us）股票出现波动，股价快速下跌5.20%。截至发稿，该股报2.10美元/股，成交量12.3874万股，换手率0.29%，振幅6.79%。最近的财报数据显示，该股实现营业收入74000.00美元，净利润-10.99百万美元，每股收益-0.25美元，毛利43000.00美元，市盈率-2.50倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080200120583d473aa&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","CRDF":"Cardiff Oncology, Inc."},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080200120583d473aa&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2256664143","content_text":"北京时间2022年08月01日23时18分，Cardiff Oncology Inc（CRDF.us）股票出现波动，股价快速下跌5.20%。截至发稿，该股报2.10美元/股，成交量12.3874万股，换手率0.29%，振幅6.79%。最近的财报数据显示，该股实现营业收入74000.00美元，净利润-10.99百万美元，每股收益-0.25美元，毛利43000.00美元，市盈率-2.50倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cardiff Oncology Inc股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)、Virax Biolabs Group Limited、Citius Pharmaceuticals Inc C/Wts 00/00/2022 (To Pur Com)涨幅较大，Geovax Labs Inc、Virax Biolabs Group Limited、Tonix Pharmaceuticals Hldg Corp较为活跃，换手率分别为567.73%、230.74%、46.75%，振幅较大的相关个股有Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)、Virax Biolabs Group Limited、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)，振幅分别为380.19%、120.74%、98.31%。Cardiff Oncology Inc公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，致力于为癌症患者开发具有最大医疗需求的适应症，包括KRAS突变的转移性结直肠癌、胰腺癌、转移性去势抵抗前列腺癌和白血病。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1},"isVote":1,"tweetType":1,"viewCount":1072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}